Kristin Muhlner
CEO and Co-founder of Affect Therapeutics

Kristin is the CEO and Co-founder of Affect Therapeutics, a leading telehealth provider of substance use disorder treatment nationally. Prior to Affect, Kristin held CEO and other executive leadership roles at a number of highly successful, fast-growing companies including webMethods (acquired by Software AG), newBrandAnalytics (acquired by Sprinklr), Sprinklr (NYSE: CXM), and Framebridge (acquired by Graham Holdings).